Skip to main content
. 2022 Nov 25;12(12):1754. doi: 10.3390/biom12121754

Table 1.

SARS-CoV-2 Mpro–drug docking summary.

e-Drug3D-lib Ligand Ciclesonide Losartan Telmisartan
Site-Specific Docking Calculated Binding
Affinity Score (kcal/mol)
1 −11.41 −9.14 −8.94
2 −11.06 −9.14 −8.29
3 −11.03 −9.14 −8.02
Blind Docking Calculated Binding
Affinity Score (kcal/mol)
1 −11.35 −9.14 −8.62
2 −11.09 −9.13 −8.72
3 −10.88 −9.14 −8.08
Drugs-lib Ligand Flezelastine Hesperidin Niceverine
Site-Specific Docking Calculated Binding
Affinity Score (kcal/mol)
1 −10.58 −9.87 −9.60
2 −10.38 −10.61 −8.90
3 −10.43 −10.72 −10.63
Blind Docking Calculated Binding
Affinity Score (kcal/mol)
1 −10.29 −10.98 −9.62
2 −10.10 −9.78 −9.05
3 −10.00 −9.16 −9.42
NP-lib Ligand NP1 NP2 NP3
Site-Specific Docking Calculated Binding
Affinity Score (kcal/mol)
1 −11.73 −10.55 −10.28
2 −10.66 −10.37 −10.28
3 −10.12 −10.47 −10.28
Blind Docking Calculated Binding
Affinity Score (kcal/mol)
1 −10.43 −10.70 −10.28
2 −10.14 −10.84 −10.28
3 −10.34 −10.65 −10.28